Discover how Nikki Wilson sheds light on the hidden dangers of silica-related lung injuries in the workplace, with insights on enforcement actions and drug formulary trends, highlighting Enlyte’s expertise in workers' compensation solutions.

 

Listen on Spotify

Despite decreases in utilization and cost per claim, opioids remain the No. 1 drug class in Enlyte’s 2024 Drug Trends Report. However, due to concerns with safety and overutilization, increased focus on usage guidelines as well as alternatives to pain management are gaining momentum — including those whose active ingredients drive from things you might not imagine, like pufferfish, cacti and chili peppers. Enlyte’s Nikki Wilson explores this and more in our Part 3 drug trends analysis.

A claim department, fatigued by change from recent workflow and regulatory changes, struggled to meet the needs of their customers and couldn’t keep up with pending bill and claim counts.

From inflation and regulatory issues to claims automation and the evolving workforce, experts weigh in with unique insight across the P&C landscape

SAN DIEGO, Calif.—As the nation faces uncertainties related to inflation, adversarial mid-term elections, workforce evolution and prescription drug costs, leaders in the property and casualty (P&C) and collision repair markets are seeking applicable information and new solutions to meet the challenges.